|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The expectations of the pharmaceutical industry with regard to primary packaging solutions for injectables have increased dramatically in recent years. Higher quality products that provide protection for valuable medications are currently in demand. Safety and ease of use for the patient, but also efficiency of the drug filling and packaging processes, are key criteria that must be met. Modern production technology, process optimisation and cost-efficiency on the one hand, health care reforms, the harmonisation of regulations and application trends on the other hand, are some of the developments that have created new challenges for manufacturing of parenteral packaging made of tubing glass.
Ampoules for High-Performance Machinability
The market for ampoules is calling for higher quality products, and several leading pharmaceutical firms that export to highly developed markets, such as Japan, have increased their requirements. The pharmaceutical market demands the highest possible safety for consumers who use ampoules, which means that process capability and process stability of the pharmaceutical company has to be optimised with top-quality ampoules.
From an end user perspective, it is important that ampoules are easy to open with maximum comfort, and more attention is now being given to the needs of new and inexperienced users. Whereas doctors and pharmacists were previously the pharmaceutical industry's primary contacts, self-medication has been playing a greater role for consumers in recent years; this has been reinforced by health care reforms in several different countries. As a result, product safety is taking on greater importance than ever before. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Olivier Leprince, Plant Manager, and Hans Peter Manser, Marketing and Sales Manager at SCHOTT
Olivier Leprince has been Plant Manager at SCHOTT France in Pont-sur-Yonne since 2001. Prior to this position, he was involved in production management for several SCHOTT plants in France over 20 years. In 2002, Olivier Leprince was also appointed TopLine Project Manager for the launch of the new product line.
Hans Peter Manser has a technical background with a buqsiness degree, completed by marketing and general management training at the IMD in Lausanne, Switzerland. He has held positions in R&D, technical support engineering, marketing and sales, with international sales and management experience, including long-term assignments in six countries worldwide. In May 2002, he became a member of the management team of SCHOTT forma vitrum, St Gallen, Switzerland and is responsible for marketing and sales.
|
|
|
|
|
|
 |
Industry Events |
 |
BioPh Europe
5-7 October 2010, Paris, France
All companies and organisations dealing with the research and development of new treatment methods made through biotechnological processes or which are derived from or use live organisms will benefit from the mix of exhibition, seminars and 121 partnering meetings at BioPh. BioPh Europe 2010 at Paris Nord Villepinte will offer you unrivalled networking and commercial opportunities in the world of drug research and manufacturing.
More info >> |
|
 |
News and Press Releases |
 |
PharmaBrand Summit 2010
Top pharmaceutical executives shared best practices at the PharmaBrand Summit
2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco
and was organised by Marcus Evans
More info >> |
|
 |
